You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Infectious Diseases
 •HIV/AIDS
 •Pregnancy and Breast Feeding
 •Neonatology and Infant Care
 •Alert me on articles by topic

Successes and Challenges in the Perinatal HIV-1 Epidemic in the United States as Illustrated by the HIV-1 Serosurvey of Childbearing Women

Arch Pediatr Adolesc Med. 2004;158:422-425.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Almost all human immunodeficiency virus type 1 (HIV-1) infections in children in the United States, as well as globally, are secondary to mother-to-child transmission (MTCT) of the virus. In the past decade, there has been impressive success in the United States and other resource-rich countries in reducing incident pediatric HIV-1 infections and a concomitant dramatic decrease in the incidence of new cases of pediatric AIDS.1 In contrast, in resource-limited settings, initiation of testing programs to allow pregnant women to learn their HIV-1 serostatus and use of effective short-course antiretroviral interventions to prevent MTCT are just now beginning to be implemented.2

SUCCESSES AND CHALLENGES

The perinatal HIV-1 epidemic in the United States can be separated into 4 partly overlapping phases. The initial phase of the epidemic occurred prior to 1994, when MTCT rates were about 25% and approximately 1500 to 1750 HIV-infected infants were born annually. The second phase, spanning 1994 to 1996, followed . . . [Full Text of this Article]


INSIGHTS FROM DATA ON HIV-1 SEROPREVALENCE IN CHILDBEARING WOMEN
Lynne M. Mofenson, MD
Pediatric, Adolescent and Maternal AIDS Branch
Center for Research for Mothers and Children
National Institute of Child Health and Human Development
National Institutes of Health
6100 Executive Blvd
Room 4B11
Rockville, MD 20852
(e-mail: LM65D@nih.gov)


RELATED ARTICLE

Trends From an HIV Seroprevalence Study Among Childbearing Women in New York State From 1988 Through 2000: A Valuable Epidemiologic Tool
Wendy P. Pulver, Donna Glebatis, Nancy Wade, Guthrie S. Birkhead, and Perry Smith
Arch Pediatr Adolesc Med. 2004;158(5):443-448.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Journey to the Motherland: Assessing Capacity for the Prevention of HIV Mother-to-Child Transmission in South Africa
Rose et al.
Home Health Care Management Practice 2007;20:50-57.
ABSTRACT  

Advances in the Prevention of Perinatal HIV-1 Transmission
Shetty and Maldonado
NeoReviews 2005;6:e12-e25.
FULL TEXT  

HIV Infection and Zidovudine Use in Childbearing Women
Sia et al.
Pediatrics 2004;114:e707-e712.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.